ALMIRALL, S.A.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 58197
 
  
 
C07D HETEROCYCLIC COMPOUNDS 37125
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 841
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 4134
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 392

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0151,264 COMBINATIONMay 21, 15Jun 01, 17[A61K]
2016/0310,457 PHARMACEUTICAL COMPOSITIONS COMPRISING DIMETHYL FUMARATEDec 05, 14Oct 27, 16[A61K]
2016/0038,512 TOPICAL PHARMACEUTICAL COMPOSITIONSOct 15, 15Feb 11, 16[A61K]
2015/0093,374 NOVEL METHODSDec 05, 14Apr 02, 15[A61K]
2012/0014,918 ADDITION SALTS OF AMINES CONTAINING HYDROXYL AND/OR CARBOXYLIC GROUPS WITH AMINO NICOTINIC ACID DERIVATIVES AS DHODH INHIBITORSMar 11, 10Jan 19, 12[A61K, A61P]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9907807 Topical pharmaceutical compositionsOct 15, 15Mar 06, 18[A61K]
9757383 Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activitiesDec 02, 15Sep 12, 17[A61K, C07D]
9737520 Aclidinium for use in improving the quality of sleep in respiratory patientsMay 23, 16Aug 22, 17[A61K]
9687478 Quinuclidine derivatives and medicinal compositions containing the sameApr 09, 16Jun 27, 17[A61K, C07D]
RE46417 Quinuclidine derivatives and their use as muscarinic M3 receptor ligandsFeb 09, 16May 30, 17[A61K, C07D, A61P]
9643961 Cyclohexylamine derivatives having β2 adrenergic antagonist and M3 muscarinic antagonist activitiesMar 14, 16May 09, 17[A61K, C07D]
9579316 Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both muscarinic receptor antagonist and β2 adrenergic receptor agonist activitiesJul 24, 14Feb 28, 17[A61K, C07D, C07C]
9562039 Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both β2 adrenergic receptor agonist and M3 muscarinic receptor antagonist activitiesFeb 27, 14Feb 07, 17[A61K, C07D, C07C]
9549934 Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activitiesDec 02, 15Jan 24, 17[A61K, C07D]
9518050 Cyclohexyl and quinuclidinyl carbamate derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activityDec 17, 13Dec 13, 16[A61K, C07D, C07C]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0189,409 MEDICAL USEAbandonedMay 21, 15Jul 06, 17[A61K, C07D]
2016/0015,704 COMBINATIONS COMPRISING MABA COMPOUNDS AND CORTICOSTEROIDSAbandonedFeb 27, 14Jan 21, 16[A61K]
2015/0328,194 NEW USE OF ACLIDINIUMAbandonedDec 13, 13Nov 19, 15[A61K]
2015/0140,099 NOVEL DOSAGE FORM AND FORMULATION OF ABEDITEROLAbandonedMay 30, 13May 21, 15[A61K]
2015/0118,312 NOVEL DOSAGE AND FORMULATIONAbandonedMay 24, 13Apr 30, 15[A61K, A61M]
2015/0111,971 TOPICAL PHARMACEUTICAL COMPOSITIONSAbandonedMay 13, 13Apr 23, 15[A61K]
2015/0065,471 SALTS OF 5-[(1R)-2-(AMINO)-1-HYDROXYETHYL]-8-HYDROXYQUINOLIN-2(1H)-ONEAbandonedMar 28, 13Mar 05, 15[A61K, C07D, C07C]
2014/0349,981 TOPICAL PHARMACEUTICAL COMPOSITIONS COMPRISING BEXAROTENE AND A CORTICOSTEROIDAbandonedDec 18, 12Nov 27, 14[A61K]
2014/0343,097 5-(2-1-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE FOR THE TREATMENT OF LUNG FUNCTIONAbandonedMar 26, 14Nov 20, 14[A61K]
2014/0200,203 TOPICAL PHARMACEUTICAL COMPOSITIONSAbandonedMay 13, 11Jul 17, 14[A61K]
2014/0170,110 PYRIDIN-2(1H)-ONE DERIVATIVES USEFUL AS MEDICAMENTS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS, TRANSPLANT REJECTION, IMMUNE-MEDIATED AND INFLAMMATORY DISEASESAbandonedMay 21, 12Jun 19, 14[A61K, C07D]
2014/0100,246 ACLIDINIUM FOR USE IN IMPROVING THE QUALITY OF SLEEP IN RESPIRATORY PATENTSAbandonedApr 11, 12Apr 10, 14[A61K]
2014/0094,442 COMBINATIONS COMPRISING ANTI-MUSCARINIC AGENTS AND CORTICOSTEROIDSAbandonedApr 02, 13Apr 03, 14[A61K]
2014/0038,928 5-(2--1-HYDROXYETHYL-8-HYDROXYQUINOLIN-2 (1H)-ONE AND ITS USE IN THE TREATMENT OF PULMONARY DISEASESAbandonedOct 08, 13Feb 06, 14[A61K, A61M]
2014/0005,178 AZABIPHENYLAMINOBENZOIC ACID DERIVATIVES AS DHODH INHIBITORSAbandonedAug 12, 13Jan 02, 14[A61K, C07D]
2013/0310,354 COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTSAbandonedJul 25, 13Nov 21, 13[A61K]
2013/0252,928 COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORSAbandonedMay 21, 13Sep 26, 13[A61K]
8536165 Azabiphenylaminobenzoic acid derivatives as DHODH inhibitorsExpiredAug 08, 08Sep 17, 13[A61K]
8524908 Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-oneExpiredMar 12, 10Sep 03, 13[C07D]
2013/0216,498 IMIDAZOPYRIDINE DERIVATIVES AS JAK INHIBITORSAbandonedDec 23, 10Aug 22, 13[A61K, C07D]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.